Handong Yang

机构：Hubei University of Medicine, Chongqing University, China National Pharmaceutical Group Corporation (China), Dongfeng General Hospital · ORCID：0000-0002-4894-8613

发表论文 33 篇 · 总被引 704 次 · h-index 12

代表论文

• GLP-1 receptor agonist as a modulator of innate immunity (2022 · Frontiers in Immunology · 被引 112)
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease (2023 · International Journal of COPD · 被引 51)
• Effect of GLP‐1/GLP‐1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis (2021 · Mediators of Inflammation · 被引 44)
• Metabolome-Wide Association Study of Multiple Plasma Metals with Serum Metabolomic Profile among Middle-to-Older-Aged Chinese Adults (2022 · Environmental Science & Technology · 被引 32)
• Lipid metabolic links between serum pyrethroid levels and the risk of incident type 2 diabetes: A mediation study in the prospective design (2023 · Journal of Hazardous Materials · 被引 24)
• Plasma miR-193b-3p Is Elevated in Type 2 Diabetes and Could Impair Glucose Metabolism (2022 · Frontiers in Endocrinology · 被引 24)